MHC Class II DRB Genotyping is Highly Predictive of In-vitro Alloreactivity in the Common Marmoset
Overview
Pathology
Authors
Affiliations
The common marmoset (Callithrix jacchus) is emerging as a promising alternative pre-clinical model for transplantation and immunological research. It is therefore important to establish a rapid and reliable method of confirming alloreactivity between donor-recipient pairs. In this study of a large marmoset colony (n=49), we firstly characterised MHC Class II genes (Caja-DRB*W1201, Caja-DRB1*03, Caja-DRB*W16) using, for the first time in this species, sequence-based allelic typing techniques. Exon 2 was amplified using M13-tailed PCR primers specific for known marmoset alleles, and sequenced using universal M13 sequencing primers and dye terminator cycle sequencing. Twenty-six genotypes involving monomorphic Caja-DRB*W1201, 8 Caja-DRB*W16 and 5 Caja-DRB1*03 alleles were observed. Two new DRB*W16 alleles were identified. Subsequently we investigated whether matching at MHC-DRB loci alone could accurately predict in-vitro alloreactivity as assessed by mixed lymphocyte reactions. Peripheral blood mononuclear cells (PBMC) isolated from fully and partially DRB-matched and fully mismatched animal pairs were mixed and co-cultured for T-cell proliferation. PBMC co-cultured from fully or partially mismatched pairs exhibited significant T cell proliferation above single cell controls (p<0.01). Mixed PBMC from fully DRB-matched pairs exhibited no proliferation over controls (p=0.3). Thus using Caja-DRB genotyping, suitably alloreactive donor-recipient pairs can be rapidly and accurately identified for use in further studies of cellular and solid organ transplantation.
Marmosets as models of infectious diseases.
Herron I, Laws T, Nelson M Front Cell Infect Microbiol. 2024; 14:1340017.
PMID: 38465237 PMC: 10921895. DOI: 10.3389/fcimb.2024.1340017.
Buckner J, Jack K, Melin A, Schoof V, Gutierrez-Espeleta G, Lima M PLoS One. 2021; 16(8):e0254604.
PMID: 34383779 PMC: 8360539. DOI: 10.1371/journal.pone.0254604.
Kametani Y, Shiina T, Suzuki R, Sasaki E, Habu S Exp Anim. 2018; 67(3):301-312.
PMID: 29415910 PMC: 6083031. DOI: 10.1538/expanim.17-0150.
Naturally occurring, physiologically normal, primate chimeras.
Sweeney C, Ward J, Vallender E Chimerism. 2012; 3(2):43-4.
PMID: 22627807 PMC: 3442812. DOI: 10.4161/chim.20729.
Gervais A, Eymard J, Toulmonde E, Bernard J Cancer Immunol Immunother. 2009; 58(11):1831-41.
PMID: 19330330 PMC: 11030287. DOI: 10.1007/s00262-009-0694-7.